LT3986890T - Benzizoksazolo sulfonamido dariniai - Google Patents
Benzizoksazolo sulfonamido dariniaiInfo
- Publication number
- LT3986890T LT3986890T LTEPPCT/IB2020/055589T LTIB2020055589T LT3986890T LT 3986890 T LT3986890 T LT 3986890T LT IB2020055589 T LTIB2020055589 T LT IB2020055589T LT 3986890 T LT3986890 T LT 3986890T
- Authority
- LT
- Lithuania
- Prior art keywords
- sulfonamide derivatives
- benzisoxazole
- benzisoxazole sulfonamide
- derivatives
- sulfonamide
- Prior art date
Links
- OIFAKIJHBGJKLD-UHFFFAOYSA-N 1,2-benzoxazole-3-sulfonamide Chemical class C1=CC=C2C(S(=O)(=O)N)=NOC2=C1 OIFAKIJHBGJKLD-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/423—Oxazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962863199P | 2019-06-18 | 2019-06-18 | |
US201962953223P | 2019-12-24 | 2019-12-24 | |
US202063025278P | 2020-05-15 | 2020-05-15 | |
PCT/IB2020/055589 WO2020254946A1 (en) | 2019-06-18 | 2020-06-16 | Benzisoxazole sulfonamide derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
LT3986890T true LT3986890T (lt) | 2023-12-11 |
Family
ID=71738189
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LTEPPCT/IB2020/055589T LT3986890T (lt) | 2019-06-18 | 2020-06-16 | Benzizoksazolo sulfonamido dariniai |
Country Status (29)
Country | Link |
---|---|
US (2) | US11492346B2 (zh) |
EP (2) | EP3986890B1 (zh) |
JP (2) | JP7352662B2 (zh) |
KR (1) | KR20220024671A (zh) |
CN (1) | CN114364672A (zh) |
AU (2) | AU2020296361A1 (zh) |
BR (1) | BR112021025528A2 (zh) |
CA (1) | CA3143666C (zh) |
CL (1) | CL2021003372A1 (zh) |
CO (1) | CO2021017504A2 (zh) |
CR (1) | CR20210627A (zh) |
DK (1) | DK3986890T3 (zh) |
EC (1) | ECSP21091615A (zh) |
ES (1) | ES2969616T3 (zh) |
FI (1) | FI3986890T3 (zh) |
HR (1) | HRP20231501T1 (zh) |
HU (1) | HUE064683T2 (zh) |
IL (1) | IL288802A (zh) |
LT (1) | LT3986890T (zh) |
MD (1) | MD3986890T2 (zh) |
MX (1) | MX2021016085A (zh) |
PE (1) | PE20220808A1 (zh) |
PL (1) | PL3986890T3 (zh) |
PT (1) | PT3986890T (zh) |
RS (1) | RS64931B1 (zh) |
SI (1) | SI3986890T1 (zh) |
TW (1) | TWI787620B (zh) |
UY (1) | UY38752A (zh) |
WO (1) | WO2020254946A1 (zh) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201810092D0 (en) * | 2018-06-20 | 2018-08-08 | Ctxt Pty Ltd | Compounds |
MX2021014441A (es) | 2019-05-31 | 2022-01-06 | Ikena Oncology Inc | Inhibidores del dominio asociado mejorador de la transcripcion (tead) y usos de los mismos. |
EP3986890B1 (en) * | 2019-06-18 | 2023-11-15 | Pfizer Inc. | Benzisoxazole sulfonamide derivatives |
AU2021308406A1 (en) * | 2020-07-15 | 2023-02-23 | Ctxt Pty Ltd | KAT6 inhibitor methods and combinations for cancer treatment |
WO2022187688A1 (en) * | 2021-03-05 | 2022-09-09 | Umbra Therapeutics Inc. | Covalent kras-binding compounds for therapeutic purposes |
WO2022187693A1 (en) * | 2021-03-05 | 2022-09-09 | Umbra Therapeutics Inc. | Covalent cdk2-binding compounds for therapeutic purposes |
CA3221048A1 (en) * | 2021-05-21 | 2022-11-24 | Aurigene Oncology Limited | Fused isoxazolyl compounds as kat6a inhibitors |
CN118382622A (zh) | 2021-07-05 | 2024-07-23 | 杭州英创医药科技有限公司 | 作为kat6抑制剂的化合物 |
TW202321263A (zh) | 2021-08-10 | 2023-06-01 | 大陸商江蘇恆瑞醫藥股份有限公司 | 磺醯胺衍生物、其製備方法及其在醫藥上的應用 |
TW202334163A (zh) * | 2021-11-16 | 2023-09-01 | 香港商英矽智能科技知識產權有限公司 | 離胺酸乙醯基轉移酶6a (kat6a)抑制劑及其用途 |
CA3241874A1 (en) * | 2021-12-13 | 2023-06-22 | Aurigene Oncology Limited | Fused benzoisoxazolyl compounds as kat6a inhibitors |
WO2023192817A1 (en) | 2022-03-28 | 2023-10-05 | Isosterix, Inc. | Inhibitors of the myst family of lysine acetyl transferases |
WO2023245150A1 (en) * | 2022-06-16 | 2023-12-21 | Prelude Therapeutics Incorporated | Kat6 targeting compounds with ubiquitin ligase binding moiety |
WO2024023703A1 (en) | 2022-07-29 | 2024-02-01 | Pfizer Inc. | Dosing regimens comprising a kat6 inhibitor for the treatment of cancer |
WO2024131772A1 (zh) * | 2022-12-20 | 2024-06-27 | 杭州中美华东制药有限公司 | 具有sting抑制作用的含肟化合物及其药物组合物和用途 |
WO2024165035A1 (zh) * | 2023-02-10 | 2024-08-15 | 江苏恒瑞医药股份有限公司 | 一种磺酰胺衍生物结晶形式及其制备方法 |
Family Cites Families (91)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2358031A (en) | 1944-09-12 | Substituted thiadiazoles | ||
US3064003A (en) | 1962-11-13 | Carboxylic acid derivatives of sub- | ||
US2525321A (en) | 1949-01-07 | 1950-10-10 | American Cyanamid Co | Hydroxybenzenesulfonamidoisoxazoles and preparation of same |
GB689281A (en) | 1950-02-18 | 1953-03-25 | Lunbeck Corp | Improvements in or relating to the production of sulphanilamido-thiadiazoles |
DE1102745B (de) | 1959-06-06 | 1961-03-23 | Boehringer & Soehne Gmbh | Verfahren zur Herstellung von 5-Sulfanilamidoisoxazolen |
BE617370A (fr) | 1961-05-09 | 1962-11-08 | Ciba Geigy | Procédé de préparation du 2,5-di-[benzoxazolyl-(2')]-thiofène |
US3332942A (en) | 1962-11-02 | 1967-07-25 | White Lab Inc | Substituted thiadiazoles |
JPS498255B1 (zh) | 1970-10-08 | 1974-02-25 | ||
US3951967A (en) | 1972-03-20 | 1976-04-20 | Merck & Co., Inc. | 7-Mercapto(or thio)-benzothiadiazine products |
US3960854A (en) | 1972-03-20 | 1976-06-01 | Merck & Co., Inc. | 7-Mercapto(or thio)-benzothiadiazine products |
DE2617809C2 (de) | 1976-04-23 | 1984-09-20 | Basf Ag, 6700 Ludwigshafen | Verfahren zur Stabilisierung von Chromdioxid-Magnetpigmenten und seine Verwendung |
JPS6042794B2 (ja) | 1977-09-27 | 1985-09-25 | 三共株式会社 | イソオキサゾリウム塩,およびその製造方法 |
US4251664A (en) | 1978-05-24 | 1981-02-17 | Henkel Corporation | Sulfonamidothiadiazoles, metal complexes thereof, and solutions containing such compounds for use in extraction of metal values |
US4172896A (en) | 1978-06-05 | 1979-10-30 | Dainippon Pharmaceutical Co., Ltd. | Methane-sulfonamide derivatives, the preparation thereof and composition comprising the same |
JPS603685B2 (ja) | 1980-04-15 | 1985-01-30 | 日本コロムビア株式会社 | 絵入りレコ−ド盤の製造方法 |
GB8427618D0 (en) | 1984-11-01 | 1984-12-05 | Shell Int Research | Anticoccidial compositions |
GB8607683D0 (en) | 1986-03-27 | 1986-04-30 | Ici Plc | Anti-tumor agents |
JPS63238006A (ja) | 1987-03-26 | 1988-10-04 | Shionogi & Co Ltd | イモチ防除剤 |
US5591761A (en) | 1993-05-20 | 1997-01-07 | Texas Biotechnology Corporation | Thiophenyl-, furyl-and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin |
US5962490A (en) | 1987-09-25 | 1999-10-05 | Texas Biotechnology Corporation | Thienyl-, furyl- and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin |
NZ231534A (en) | 1988-11-29 | 1992-02-25 | Warner Lambert Co | 3,5-di-t-butyl-4-hydroxyphenyl-triazoles, oxadiazoles and thiadiazoles; anti-inflammatory compositions |
JPH03258771A (ja) | 1990-03-09 | 1991-11-19 | Tosoh Corp | スルホンアミド誘導体、その製法及びそれを有効成分として含有する除草剤 |
TW224462B (zh) | 1992-02-24 | 1994-06-01 | Squibb & Sons Inc | |
FR2690160A1 (fr) | 1992-04-15 | 1993-10-22 | Rhone Poulenc Rorer Sa | Application de dérivés d'acide 2H-1,2,4-benzothiadiazine-1,1-dioxyde-3-carboxylique à la préparation de médicaments, les produits nouveaux, leur préparation et les médicaments les contenant. |
NZ247440A (en) | 1992-05-06 | 1995-04-27 | Squibb & Sons Inc | Phenyl sulphonamide derivatives, preparation and pharmaceutical compositions thereof |
FI941826A (fi) | 1993-04-21 | 1994-10-22 | Takeda Chemical Industries Ltd | Menetelmät ja koostumukset elimen hypofunktion ennaltaehkäisemiseksi ja/tai terapeuttiseksi hoitamiseksi |
JP3901229B2 (ja) | 1994-05-13 | 2007-04-04 | Ntn株式会社 | 耐熱・潤滑性樹脂組成物 |
AU711968B2 (en) | 1995-04-04 | 1999-10-28 | Encysive Pharmaceuticals Inc. | Thienyl-, furyl-, pyrrolyl- and biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin |
US5804585A (en) | 1996-04-15 | 1998-09-08 | Texas Biotechnology Corporation | Thieno-pyridine sulfonamides derivatives thereof and related compounds that modulate the activity of endothelin |
JP2002514192A (ja) | 1996-11-13 | 2002-05-14 | セフアロン・インコーポレーテツド | ベンゾチアゾおよび関連の複素環基を含有するシステインおよびセリンプロテアーゼ阻害剤 |
TR200101905T2 (tr) | 1997-04-28 | 2002-06-21 | Texas Biotechnology Corporation | Endotelin ile ilgili hastalıkların tedavisinde kullanılan sülfanoamidler. |
US5783705A (en) | 1997-04-28 | 1998-07-21 | Texas Biotechnology Corporation | Process of preparing alkali metal salys of hydrophobic sulfonamides |
IL148698A0 (en) | 1999-09-17 | 2002-09-12 | Cor Therapeutics Inc | INHIBITORS OF FACTOR Xa |
WO2001049289A1 (en) | 1999-12-31 | 2001-07-12 | Texas Biotechnology Corporation | Pharmaceutical and veterinary uses of endothelin antagonists |
WO2001064642A2 (en) | 2000-02-29 | 2001-09-07 | Cor Therapeutics, Inc. | Benzamides and related inhibitors of factor xa |
GB0127344D0 (en) | 2001-11-14 | 2002-01-02 | Cancer Res Ventures Ltd | Assay method |
IL160630A0 (en) | 2001-11-22 | 2004-07-25 | Biovitrum Ab | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
JP2003292485A (ja) | 2002-04-01 | 2003-10-15 | Yamanouchi Pharmaceut Co Ltd | スルホンアミド誘導体 |
TW200505902A (en) | 2003-03-20 | 2005-02-16 | Schering Corp | Cannabinoid receptor ligands |
CA2525945A1 (en) | 2003-05-21 | 2004-12-02 | Biovitrum Ab | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type i |
WO2004113310A1 (en) | 2003-06-25 | 2004-12-29 | Biovitrum Ab | Use of an inhibitor of 11-b-hydroxysteroid dehydrogenase type 1 compounds for promoting wound healing |
KR20060097105A (ko) | 2003-07-22 | 2006-09-13 | 얀센 파마슈티카 엔.브이. | C-fms 키나아제 저해제로서의 퀴놀리논 유도체 |
CA2539227A1 (en) | 2003-08-08 | 2005-02-17 | Vertex Pharmaceuticals Incorporated | Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain |
US7615563B2 (en) | 2003-08-08 | 2009-11-10 | Gonzalez Iii Jesus E | Compositions useful as inhibitors of voltage-gated sodium channels |
US7973161B2 (en) | 2003-11-13 | 2011-07-05 | Abbott Laboratories | Apoptosis promoters |
US7642260B2 (en) | 2003-11-13 | 2010-01-05 | Abbott Laboratories, Inc. | Apoptosis promoters |
US7767684B2 (en) * | 2003-11-13 | 2010-08-03 | Abbott Laboratories | Apoptosis promoters |
US8614318B2 (en) | 2003-11-13 | 2013-12-24 | Abbvie Inc. | Apoptosis promoters |
WO2005049593A2 (en) * | 2003-11-13 | 2005-06-02 | Abbott Laboratories | N-acylsulfonamide apoptosis promoters |
AU2005295902A1 (en) | 2004-10-12 | 2006-04-27 | Decode Genetics Ehf | Aryl sulfonamide peri-substituted bicyclics for occlusive artery disease |
EP1888558B1 (en) | 2005-05-16 | 2011-10-05 | Vertex Pharmaceuticals, Inc. | Bicyclic derivatives as modulators of ion channels |
DE102005038947A1 (de) | 2005-05-18 | 2006-11-30 | Grünenthal GmbH | Substituierte Benzo[d]isoxazol-3-yl-amin-Verbindungen und deren Verwendung in Arzneimitteln |
JP2009510147A (ja) | 2005-10-06 | 2009-03-12 | サノフィ−アベンティス | N−[1,3,4]−チアジアゾール−2−イル−ベンゼンスルホンアミド類、それらの製造方法及び医薬品としてのそれらの使用 |
WO2007039174A2 (en) | 2005-10-06 | 2007-04-12 | Sanofi-Aventis | Bicyclic aryl-sulfonic acid [1,3,4]-thiadiazol-2-yl-amides, processes for their preparation and their use as pharmaceuticals |
DE102005055355A1 (de) | 2005-11-21 | 2007-10-31 | Merck Patent Gmbh | 3,6-Dihydro-2-oxo-6H-[1,3,4]thiadiazinderivate |
EP1963281A2 (en) | 2005-12-21 | 2008-09-03 | Vertex Pharmaceuticals, Inc. | Heterocyclic derivatives as modulators of ion channels |
EP2054056A4 (en) | 2006-08-16 | 2010-08-25 | J David Gladstone Inst A Testa | SMALL MOLECULAR INHIBITORS OF KYNURENINE-3-MONOOXYGENASE |
WO2008064116A2 (en) | 2006-11-16 | 2008-05-29 | Abbott Laboratories | Method of preventing or treating organ, hematopoietic stem cell or bone marrow transplant rejection |
EP2094671A1 (en) | 2006-11-20 | 2009-09-02 | Alantos Pharmaceuticals Holding, Inc. | Heterobicyclic metalloprotease inhibitors |
US20080194557A1 (en) | 2007-01-18 | 2008-08-14 | Joseph Barbosa | Methods and compositions for the treatment of pain, inflammation and cancer |
JP5460589B2 (ja) | 2007-07-13 | 2014-04-02 | アイカジェン, インコーポレイテッド | ナトリウムチャネル阻害物質 |
BRPI0819093A2 (pt) | 2007-11-01 | 2017-05-02 | Sirtris Pharmaceuticals Inc | compostos moduladores de sirtuína |
WO2009086303A2 (en) | 2007-12-21 | 2009-07-09 | University Of Rochester | Method for altering the lifespan of eukaryotic organisms |
WO2009080223A1 (en) | 2007-12-26 | 2009-07-02 | Sanofi-Aventis | Cyclic pyridyl-n-(1,3,4)-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals |
CA2734254C (en) | 2008-08-13 | 2018-06-05 | Smed-Ta/Td, Llc | Orthopaedic screws |
WO2010046780A2 (en) | 2008-10-22 | 2010-04-29 | Institut Pasteur Korea | Anti viral compounds |
US8993556B2 (en) | 2009-04-21 | 2015-03-31 | Nerviano Medical Sciences S.R.L. | Resorcinol derivatives as HSP90 inhibitors |
UA107360C2 (en) | 2009-08-05 | 2014-12-25 | Biogen Idec Inc | Bicyclic aryl sphingosine 1-phosphate analogs |
WO2011082400A2 (en) | 2010-01-04 | 2011-07-07 | President And Fellows Of Harvard College | Modulators of immunoinhibitory receptor pd-1, and methods of use thereof |
WO2011085575A1 (zh) | 2010-01-15 | 2011-07-21 | 江苏省农药研究所股份有限公司 | 邻杂环甲酰苯胺类化合物及其合成方法和应用 |
CN101747325A (zh) | 2010-01-15 | 2010-06-23 | 江苏省农药研究所股份有限公司 | 邻杂环甲酰苯胺类化合物及其合成方法和应用 |
CN101845043A (zh) | 2010-01-15 | 2010-09-29 | 江苏省农药研究所股份有限公司 | 邻杂环甲酰苯胺类化合物及其合成方法和应用 |
JP2013525438A (ja) | 2010-04-29 | 2013-06-20 | アメリカ合衆国 | ヒトピルビン酸キナーゼ活性剤 |
TW201210597A (en) | 2010-06-09 | 2012-03-16 | Gilead Sciences Inc | Inhibitors of hepatitis C virus |
CA2804716A1 (en) | 2010-07-12 | 2012-01-19 | Pfizer Limited | Chemical compounds |
WO2012080729A2 (en) | 2010-12-14 | 2012-06-21 | Electrophoretics Limited | CASEIN KINASE 1δ (CK1δ) INHIBITORS |
US8987271B2 (en) | 2010-12-22 | 2015-03-24 | Eutropics Pharmaceuticals, Inc. | 2,2′-biphenazine compounds and methods useful for treating disease |
WO2012129562A2 (en) | 2011-03-24 | 2012-09-27 | The Scripps Research Institute | Compounds and methods for inducing chondrogenesis |
PL220630B1 (pl) | 2012-12-28 | 2015-11-30 | Inst Immunologii I Terapii Doświadczalnej Pan | Nowe sulfonamidowe pochodne izoksazolo[5,4-b]pirydyny o aktywności przeciwbakteryjnej, sposób ich wytwarzania oraz nowe zastosowanie 3-aminoizoksazolo[5,4-b]pirydyny |
WO2014144545A2 (en) | 2013-03-15 | 2014-09-18 | Genentech, Inc. | Substituted benzoxazoles and methods of use thereof |
WO2015102929A1 (en) | 2013-12-30 | 2015-07-09 | Novartis Ag | Tricyclic sulfonamide derivatives |
US10065945B2 (en) | 2014-01-24 | 2018-09-04 | Merck Sharp & Dohme Corp. | Isoquinoline derivatives as MGAT2 inhibitors |
GB201510019D0 (en) | 2015-06-09 | 2015-07-22 | Cancer Therapeutics Crc Pty Ltd | Compounds |
WO2017002120A1 (en) | 2015-07-02 | 2017-01-05 | Yeda Research And Development Co. Ltd. | Selective inhibitors of senescent cells and uses thereof |
WO2017098421A1 (en) | 2015-12-08 | 2017-06-15 | Glaxosmithkline Intellectual Property Development Limited | Benzothiadiazine compounds |
CN107098846B (zh) * | 2016-02-26 | 2020-10-09 | 中国医学科学院药物研究所 | N-酰基磺酰胺类FBPase抑制剂、其制备方法、药物组合物及用途 |
WO2018081167A1 (en) | 2016-10-24 | 2018-05-03 | Yumanity Therapeutics | Compounds and uses thereof |
US20220267260A1 (en) | 2016-11-29 | 2022-08-25 | Epizyme, Inc. | Compounds containing a sulfonic group as kat inhibitors |
WO2018226976A1 (en) | 2017-06-08 | 2018-12-13 | Kura Oncology, Inc. | Methods and compositions for inhibiting the interaction of menin with mll proteins |
GB201810092D0 (en) | 2018-06-20 | 2018-08-08 | Ctxt Pty Ltd | Compounds |
EP3986890B1 (en) | 2019-06-18 | 2023-11-15 | Pfizer Inc. | Benzisoxazole sulfonamide derivatives |
-
2020
- 2020-06-16 EP EP20743773.2A patent/EP3986890B1/en active Active
- 2020-06-16 MD MDE20220478T patent/MD3986890T2/ro unknown
- 2020-06-16 WO PCT/IB2020/055589 patent/WO2020254946A1/en active Application Filing
- 2020-06-16 JP JP2021574753A patent/JP7352662B2/ja active Active
- 2020-06-16 PE PE2021002180A patent/PE20220808A1/es unknown
- 2020-06-16 DK DK20743773.2T patent/DK3986890T3/da active
- 2020-06-16 CA CA3143666A patent/CA3143666C/en active Active
- 2020-06-16 ES ES20743773T patent/ES2969616T3/es active Active
- 2020-06-16 LT LTEPPCT/IB2020/055589T patent/LT3986890T/lt unknown
- 2020-06-16 HR HRP20231501TT patent/HRP20231501T1/hr unknown
- 2020-06-16 PT PT207437732T patent/PT3986890T/pt unknown
- 2020-06-16 EP EP23203023.9A patent/EP4299135A3/en active Pending
- 2020-06-16 UY UY0001038752A patent/UY38752A/es unknown
- 2020-06-16 US US16/902,515 patent/US11492346B2/en active Active
- 2020-06-16 FI FIEP20743773.2T patent/FI3986890T3/fi active
- 2020-06-16 HU HUE20743773A patent/HUE064683T2/hu unknown
- 2020-06-16 BR BR112021025528A patent/BR112021025528A2/pt unknown
- 2020-06-16 MX MX2021016085A patent/MX2021016085A/es unknown
- 2020-06-16 CN CN202080057621.7A patent/CN114364672A/zh active Pending
- 2020-06-16 KR KR1020227001722A patent/KR20220024671A/ko not_active Application Discontinuation
- 2020-06-16 CR CR20210627A patent/CR20210627A/es unknown
- 2020-06-16 AU AU2020296361A patent/AU2020296361A1/en not_active Abandoned
- 2020-06-16 PL PL20743773.2T patent/PL3986890T3/pl unknown
- 2020-06-16 SI SI202030335T patent/SI3986890T1/sl unknown
- 2020-06-16 RS RS20231177A patent/RS64931B1/sr unknown
- 2020-06-17 TW TW109120469A patent/TWI787620B/zh active
-
2021
- 2021-12-08 IL IL288802A patent/IL288802A/en unknown
- 2021-12-16 CL CL2021003372A patent/CL2021003372A1/es unknown
- 2021-12-17 EC ECSENADI202191615A patent/ECSP21091615A/es unknown
- 2021-12-21 CO CONC2021/0017504A patent/CO2021017504A2/es unknown
-
2022
- 2022-09-16 US US17/946,101 patent/US20230174522A1/en active Pending
-
2023
- 2023-09-15 JP JP2023149699A patent/JP2023175821A/ja active Pending
- 2023-11-30 AU AU2023274178A patent/AU2023274178A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL288802A (en) | Benzisoxazole sulfonamide derivatives | |
GB2572126B (en) | Pharmaceutical | |
EP3615539A4 (en) | 2-AMINO-QUINOLEINE DERIVATIVES | |
GB201800072D0 (en) | Pharmaceutical | |
GB2572125B (en) | Pharmaceutical | |
TWI799429B (zh) | 新穎氮喹啉衍生物 | |
ZA202204675B (en) | New methylquinazolinone derivatives | |
IL283990A (en) | Modified oxopyridine derivatives | |
EP3290001A4 (en) | Vibrator for toothbrush | |
IL289197A (en) | History of 2-hydroxycycloalkane-1-carbamoyl | |
EP3773566A4 (en) | OX2R CONNECTIONS | |
HUE064831T2 (hu) | Szulfonil-amino-benzamid származékok | |
IL279938A (en) | History of spirochroman | |
IL290815A (en) | History of alpha-d-galactopyranoside | |
IL286434A (en) | Nicoandyl derivatives | |
EP3243510A4 (en) | Sulfonamide pharmaceutical composition | |
GB201919212D0 (en) | Dihydro-cyclopenta-isoquinoline sulfonamides derivatives | |
GB2583973B (en) | Tethers | |
HUE062256T2 (hu) | Dihidrokromén-származékok | |
GB201819164D0 (en) | Artificial-intelligence-assisted surgery | |
EP3595659A4 (en) | AZA DIHYDRO ACRIDONE DERIVATIVES | |
EP3595647A4 (en) | ARYLPIPERIDE DERIVATIVES | |
GB201919210D0 (en) | Dihydro-cyclopenta-isoquinoline derivatives | |
GB201806948D0 (en) | Derivatives | |
EP3820535A4 (en) | N-ACETYLGALACTOSAMINE FUNCTIONALITY DENDRIME RELEASING AGENT FOR PRE-TARGETED RADIOIMMUNOTHERAPY ON DOTA |